Frequently Asked Questions

Bacosane® is a natural standardized extract of Bacopa monnieri containing eight bioactive compounds — Asiatic acid, Ebelin lactone, Bacogenin A1, Bhramic acid, Bacoside A3, Bacopaside I, Bacopaside II and Jujubogenin — investigated in laboratory and animal studies for antioxidant, stress-support, synaptic and cognitive-health applications.

Bacosane® is standardized to eight bioactive compounds from Bacopa monnieri, including Asiatic acid, Ebelin lactone, Bacogenin A1, Bhramic acid, Bacoside A3, Bacopaside I, Bacopaside II and Jujubogenin. The exact assay and analytical method are stated in the current specification and batch COA.

Bacosane® combines controlled standardization with a defined multi-bioactive profile, product-specific preclinical research and intellectual-property protection. It is characterized by its Asiatic acid, Ebelin lactone, Bacogenin A1, Bhramic acid, Bacoside A3, Bacopaside I, Bacopaside II and Jujubogenin content.

Asiatic acid, Ebelin lactone, Bacogenin A1, Bhramic acid, Bacoside A3, Bacopaside I, Bacopaside II and Jujubogenin — associated with Bacosane®'s investigated neurological and antioxidant activities.

Yes. Bacosane® is associated with India Patent Application 202141036735, PCT Application PCT/IB2021/059307 and granted US Patent US 12,357,924 B2. Patent status is not regulatory approval.

Bacosane® is available in standardized grades ranging from 10% to 50% bacosides, offering versatile formulation options. Daily intake for standardized Bacopa monnieri extracts typically ranges between 150 mg and 300 mg per day depending on the active grade concentration and finished product positioning. Contact our technical team for specific formulation guidelines.

Preclinical and traditional evidence demonstrates support for acute stress response, while sustained cognitive, synaptic and memory benefits develop with consistent daily intake over 4 to 12 weeks. Ongoing human clinical studies are evaluating detailed onset dynamics.

Yes. In the DPPH radical-scavenging assay, Bacosane® showed concentration-dependent antioxidant activity with an IC50 of 150.50 µg/mL versus 87.25 µg/mL for BHT — an in vitro result.

Acute (5,000 mg/kg) and 28-day subacute (up to 1,000 mg/kg/day) oral-toxicity assessments in albino rats reported no mortality, apparent toxicity or significant therapy-related differences vs controls. These preclinical evaluations confirm an exceptionally high safety threshold.

Preclinical toxicology studies (acute 5,000 mg/kg and 28-day sub-acute up to 1,000 mg/kg/day) demonstrated an excellent safety profile with no observed toxicity. As with any botanical ingredient, formulators should provide standard consumer guidance for pregnant or lactating individuals.

Star Hi Herbs manufactures Bacosane® in certified facilities (FSSC 22000, WHO-GMP, ISO 9001:2015, FSSAI, Kosher, Halal) to meet international regulatory standards. Finished-product brands can verify compliance in each target market with our comprehensive QA dossiers.

Yes. Bacosane® is versatile and suitable for hard-shell capsules, tablets, powder blends, sachets and gummies. Stability and dissolution testing are supported by our technical documentation.

Use levels are tailored based on the chosen bioactive grade (10% to 50% bacosides), the finished product delivery format, and regional dietary guidelines. Contact our technical specialists for formulation and dosage recommendations.

The standard MOQ for herbal extracts is generally 100 kg, subject to grade, availability, packaging and commercial terms. Request a quotation for current MOQ and pricing.

Yes. Qualified formulators, manufacturers and finished-product brands may request a sample. Standard laboratory samples are generally available in 25–50 g quantities.

Use of the Bacosane® name or logo requires written authorization and compliance with the applicable trademark-licensing terms.

Star Hi Herbs supplies botanical ingredients to international markets. Availability, documentation and shipping depend on destination and its import regulations.